MetLife to buy Versant Health for $1.68 billion

Insurer MetLife Inc has agreed to buy vision-care benefits company Versant Health for $1.68 billion from an investor group led by Centerbridge Partners and FFL Partners, it said on Thursday.

The deal is expected to close in the fourth quarter of 2020, the company said in a statement. – Reuters

Share this:

Related Post

Stay Updated on Medical Equipment and Devices industry.
Receive our Daily Newsletter.